• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Abeona Therapeutics (NQ: ABEO )

    6.250 -0.160 (-2.50%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 219,108
    Open 6.470
    Bid (Size) 6.260 (3)
    Ask (Size) 6.720 (1)
    Prev. Close 6.410
    Today's Range 6.220 - 6.470
    52wk Range 3.050 - 9.010
    Shares Outstanding 43,314,397
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
    From Abeona Therapeutics Inc.
    Via GlobeNewswire

    Performance

    YTD
    +13.02%
    +13.02%
    1 Month
    +0.32%
    +0.32%
    3 Month
    +32.98%
    +32.98%
    6 Month
    +35.87%
    +35.87%
    1 Year
    +57.83%
    +57.83%

    More News

    Read More
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    ABEO Stock Earnings: Abeona Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
    Via AB Newswire
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Crude Oil Moves Higher; General Motors Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.